Abstract
Because androgen therapy is known to increase 2,3-diphosphoglycerate in the erythrocytes of patients with chronic renal failure, the possibility that it might have a similar effect on patients with chronic obstructive pulmonary disease appeared worth investigating. Results of a small study appear promising, with improvement in stress tolerance and general well-being. Pulmonary function was not improved, and the severity of pulmonary disease was not affected, but further investigation of the treatment appears to be warranted.
| Original language | American English |
|---|---|
| Journal | Chest |
| Volume | 76 |
| State | Published - Jan 1 1980 |
Keywords
- 2
- 3 diphosphoglyceric acid
- androgen
- nandrolone decanoate
- adult
- aged
- blood analysis
- blood and hemopoietic system
- chronic obstructive lung disease
- drug efficacy
- electrocardiography
- erythrocyte
- heart
- human
- human cell
- intramuscular drug administration
- lung function
- major clinical study
- respiratory system
- therapy
- Diphosphoglyceric Acids
- Erythrocytes
- Female
- Lung Diseases
- Obstructive
- Male
- Middle Age
- Nandrolone
Disciplines
- Medicine and Health Sciences